文献速递复苏、休克与脓毒症创伤与烧伤重症综合管理与镇静镇痛

间充质干细胞胞外囊泡减轻失血性休克与创伤小鼠模型中小肠和肺的血管通透性及损伤

Mesenchymal stem cell extracellular vesicles mitigate vascular permeability and injury in the small intestine and lung in a mouse model of hemorrhagic shock and trauma.
PubMed 文献 · J Trauma Acute Care Surg · 2022-01-01
一句话结论小鼠失血性休克与创伤模型中,人源间充质干细胞及其胞外囊泡均降低小肠和肺血管通透性并减轻组织损伤,胞外囊泡可能成为无细胞疗法。

该研究在失血性休克与创伤(HS/T)小鼠模型中,比较乳酸林格液(LR)、间充质干细胞(MSC)和MSC来源胞外囊泡(MSC EVs)对小肠和肺血管通透性及组织病理损伤的影响,并在体外用Caco-2肠上皮细胞单层评估MSC条件培养基(CM)和MSC EVs对过氧化氢(H2O2)攻击后通透性的作用。体内结果显示MSC和MSC EVs均显著降低小肠和肺血管通透性并减轻组织病理损伤。体外结果显示MSC CM而非MSC EVs能减轻H2O2攻击后Caco-2细胞单层通透性增加。作者认为MSC EVs再现了MSC在体内的效应,可能是针对HS/T多器官功能障碍的潜在无细胞疗法,并称这是首个在HS/T动物模型中证明MSC EVs改善肠道和肺损伤的研究。

要点

  • HS/T小鼠中,小肠血管通透性(荧光单位):假手术组456 ± 88、LR组1067 ± 295、MSC组765 ± 258、MSC EV组715 ± 200,MSC与MSC EVs均显著降低。
  • HS/T小鼠中,肺血管通透性(荧光单位):假手术组297 ± 155、LR组791 ± 331、MSC组331 ± 172、MSC EV组303 ± 88,MSC与MSC EVs均显著降低。
  • MSC和MSC EVs均减轻小肠和肺的组织病理损伤。
  • 体外Caco-2单层经H2O2攻击后,MSC条件培养基(CM)而非MSC EVs能减轻通透性增加。
  • 作者认为MSC EVs可能是针对HS/T多器官功能障碍的潜在无细胞疗法;这是首个在HS/T动物模型中证明MSC EVs改善肠道和肺损伤的研究。

适用人群与场景

  • HS/T小鼠模型(体内实验);Caco-2人肠上皮细胞单层(体外实验)

研究设计与关键结果

  • 研究类型:动物实验(小鼠HS/T模型)及体外细胞实验;样本量原文未报告。
  • 体内分组:假手术组、HS/T+乳酸林格液(LR)组、HS/T+MSC组、HS/T+MSC EVs组。
  • 小肠血管通透性(荧光单位):假手术组456 ± 88、LR组1067 ± 295、MSC组765 ± 258、MSC EV组715 ± 200;MSC与MSC EVs较LR均显著降低。
  • 肺血管通透性(荧光单位):假手术组297 ± 155、LR组791 ± 331、MSC组331 ± 172、MSC EV组303 ± 88;MSC与MSC EVs较LR均显著降低。
  • MSC和MSC EVs均减轻小肠和肺的组织病理损伤。
  • 体外:Caco-2细胞单层经H2O2攻击后,MSC条件培养基(CM)而非MSC EVs能减轻通透性增加。

证据类型、等级与局限

  • 证据类型:动物实验(小鼠HS/T模型)及体外细胞实验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为MSC EVs可能是针对HS/T多器官功能障碍的潜在无细胞疗法。
  • 作者指出这是首个在HS/T动物模型中证明MSC EVs改善肠道和肺损伤的研究。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Hemorrhagic shock and trauma (HS/T)-induced gut injury may play a critical role in the development of multi-organ failure. Novel therapies that target gut injury and vascular permeability early after HS/T could have substantial impacts on trauma patients. In this study, we investigate the therapeutic potential of human mesenchymal stem cells (MSCs) and MSC-derived extracellular vesicles (MSC EVs) in vivo in HS/T in mice and in vitro in Caco-2 human intestinal epithelial cells.

METHODS: In vivo, using a mouse model of HS/T, vascular permeability to a 10-kDa dextran dye and histopathologic injury in the small intestine and lungs were measured among mice. Groups were (1) sham, (2) HS/T + lactated Ringer's (LR), (3) HS/T + MSCs, and (4) HS/T + MSC EVs. In vitro, Caco-2 cell monolayer integrity was evaluated by an epithelial cell impedance assay. Caco-2 cells were pretreated with control media, MSC conditioned media (CM), or MSC EVs, then challenged with hydrogen peroxide (H2O2).

RESULTS: In vivo, both MSCs and MSC EVs significantly reduced vascular permeability in the small intestine (fluorescence units: sham, 456 ± 88; LR, 1067 ± 295; MSC, 765 ± 258; MSC EV, 715 ± 200) and lung (sham, 297 ± 155; LR, 791 ± 331; MSC, 331 ± 172; MSC EV, 303 ± 88). Histopathologic injury in the small intestine and lung was also attenuated by MSCs and MSC EVs. In vitro, MSC CM but not MSC EVs attenuated the increased permeability among Caco-2 cell monolayers challenged with H2O2.

CONCLUSION: Mesenchymal stem cell EVs recapitulate the effects of MSCs in reducing vascular permeability and injury in the small intestine and lungs in vivo, suggesting MSC EVs may be a potential cell-free therapy targeting multi-organ dysfunction in HS/T. This is the first study to demonstrate that MSC EVs improve both gut and lung injury in an animal model of HS/T.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Barry M, Trivedi A, Pathipati P, et al. Mesenchymal stem cell extracellular vesicles mitigate vascular permeability and injury in the small intestine and lung in a mouse model of hemorrhagic shock and trauma. J Trauma Acute Care Surg. 2022. PMID: 34882596. doi:10.1097/TA.0000000000003487

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。